The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI
Open accessAbstract
BACKGROUND: Medication-induced salivary gland dysfunction (MISGD), xerostomia (sensation of oral dryness), and subjective sialorrhea cause significant morbidity and impair quality of life. However, no evidence-based lists of the medications that cause these disorders exist. OBJECTIVE: Our objective was to compile a list of medications affecting salivary gland function and inducing xerostomia or subjective sialorrhea. DATA SOURCES: Electronic databases were searched for relevant articles published until June 2013. Of 3867 screened records, 269 had an acceptable degree of relevance, quality of methodology, and strength of evidence. We found 56 chemical substances with a higher level of evidence and 50 with a moderate level of evidence of causing the above-mentioned disorders. At the first level of the Anatomical Therapeutic Chemical (ATC) classification system, 9 of 14 anatomical groups were represented, mainly the alimentary, cardiovascular, genitourinary, nervous, and respiratory systems. Management strategies include substitution or discontinuation of medications whenever possible, oral or systemic therapy with sialogogues, administration of saliva substitutes, and use of electro-stimulating devices. LIMITATIONS: While xerostomia was a commonly reported outcome, objectively measured salivary flow rate was rarely reported. Moreover, xerostomia was mostly assessed as an adverse effect rather than the primary outcome of medication use. This study may not include some medications that could cause xerostomia when administered in conjunction with others or for which xerostomia as an adverse reaction has not been reported in the literature or was not detected in our search. CONCLUSIONS: We compiled a comprehensive list of medications with documented effects on salivary gland function or symptoms that may assist practitioners in assessing patients who complain of dry mouth while taking medications. The list may also prove useful in helping practitioners anticipate adverse effects and consider alternative medications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Gadde, K. M., Allison, D. B., Ryan, D. H., Peterson, C. A., Troupin, B., Schwiers, M. L., & Day, W. W. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60205-5 · Cited by 1,064
Greenway, F. L., Fujioka, K., Plodkowski, R. A., Mudaliar, S., Guttadauria, M., Erickson, J., Kim, D. D., & Dunayevich, E. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60888-4 · Cited by 1,036
Allison, D. B., Gadde, K. M., Garvey, W. T., Peterson, C. A., Schwiers, M. L., Najarian, T., Tam, P. Y., Troupin, B., & Day, W. W. (2012) · Obesity · doi:10.1038/oby.2011.330 · Cited by 711
Dawes, C. (1987) · Journal of Dental Research · doi:10.1177/00220345870660s107 · Cited by 634
Self-citationThe functions of human saliva: A review sponsored by the World Workshop on Oral Medicine VI
Dawes, C., Pedersen, A. M. L., Villa, A., Ekström, J., Proctor, G. B., Vissink, A., Aframian, D., McGowan, R., Aliko, A., Narayana, N., et al. (2015) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2015.03.004 · Cited by 572
Self-citationDouble-blind naltrexone and placebo comparison study in the treatment of pathological gambling
Kim, S. W., Grant, J. E., Adson, D. E., & Shin, Y. C. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01079-4 · Cited by 503
Gilron, I., Bailey, J. M., Tu, D., Holden, R. R., Jackson, A. C., & Houlden, R. L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61081-3 · Cited by 500
Drug effects on salivary glands: dry mouth
Scully CBE, C. (2003) · Oral Diseases · doi:10.1034/j.1601-0825.2003.03967.x · Cited by 472
Doody, R. S., Gavrilova, S. I., Sano, M., Thomas, R. G., Aisen, P. S., Bachurin, S. O., Seely, L., & Hung, D. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61074-0 · Cited by 460
Katona, C., Hansen, T., & Olsen, C. K. (2012) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3283542457 · Cited by 445
Fluoxetine in the Treatment of Premenstrual Dysphoria
Steiner, M., Steinberg, S., Stewart, D., Carter, D., Berger, C., Reid, R., Grover, D., & Streiner, D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506083322301 · Cited by 445
A reference guide to drugs and dry mouth – 2nd edition
Sreebny, L. M., & Schwartz, S. S. (1997) · Gerodontology · doi:10.1111/j.1741-2358.1997.00033.x · Cited by 433
Khullar, V., Amarenco, G., Angulo, J. C., Cambronero, J., Høye, K., Milsom, I., Radziszewski, P., Rechberger, T., Boerrigter, P., Drogendijk, T., et al. (2013) · European Urology · doi:10.1016/j.eururo.2012.10.016 · Cited by 432
Polosa, R., Caponnetto, P., Morjaria, J. B., Papale, G., Campagna, D., & Russo, C. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-786 · Cited by 432
Muscarinic receptor antagonists for overactive bladder
Abrams, P., & Andersson, K. (2007) · BJU International · doi:10.1111/j.1464-410x.2007.07205.x · Cited by 405
Young, A. H., McElroy, S. L., Bauer, M., Philips, N., Chang, W., Olausson, B., Paulsson, B., Brecher, M., & EMBOLDEN I (Trial 001) Investigators (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04995gre · Cited by 390
Detke, M. J., Lu, Y., Goldstein, D. J., Hayes, J. R., & Demitrack, M. A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0407 · Cited by 384
Bowden, C. L., Grunze, H., Mullen, J., Brecher, M., Paulsson, B., Jones, M., Vågerö, M., & Svensson, K. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0116 · Cited by 376
Chou, R., Peterson, K., & Helfand, M. (2004) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2004.05.002 · Cited by 375
A Reference Guide to Drugs and Dry Mouth
Sreebny, L. M., & Schwartz, S. S. (1986) · Gerodontology · doi:10.1111/j.1741-2358.1986.tb00055.x · Cited by 334
Clozapine versus typical neuroleptic medication for schizophrenia
Essali, A., Al-Haj Haasan, N., Li, C., & Rathbone, J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000059.pub2 · Cited by 329
McElroy, S. L., Weisler, R. H., Chang, W., Olausson, B., Paulsson, B., Brecher, M., Agambaram, V., Merideth, C., Nordenhem, A., Young, A. H., et al. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04942gre · Cited by 328
Gelenberg, A. J., Lydiard, R. B., Rudolph, R. L., Aguiar, L., Haskins, J. T., & Salinas, E. (2000) · JAMA · doi:10.1001/jama.283.23.3082 · Cited by 296
Kerstjens, H. A. M., Disse, B., Schröder-Babo, W., Bantje, T. A., Gahlemann, M., Sigmund, R., Engel, M., & van Noord, J. A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.04.039 · Cited by 276
Biederman, J., Mick, E., Surman, C., Doyle, R., Hammerness, P., Harpold, T., Dunkel, S., Dougherty, M., Aleardi, M., & Spencer, T. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.011 · Cited by 267
Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain
Semenchuk, M. R., Sherman, S., & Davis, B. (2001) · Neurology · doi:10.1212/wnl.57.9.1583 · Cited by 256
A dverse D rug R eactions in the O rofacial R egion
Scully, C., & Bagan, J.-V. (2004) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130401500405 · Cited by 254
Fulton, B., & Goa, K. L. (1997) · Drugs · doi:10.2165/00003495-199753020-00007 · Cited by 250
Safety of mirtazapine: a review
Montgomery, S. A. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199512004-00006 · Cited by 214
Bauer, M., Pretorius, H. W., Constant, E. L., Earley, W. R., Szamosi, J., & Brecher, M. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04629 · Cited by 210
Tollefson, G. D., Birkett, M. A., Kiesler, G. M., & Wood, A. J. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01026-x · Cited by 202
Schuman, J. S. (1997) · Archives of Ophthalmology · doi:10.1001/archopht.1997.01100160017002 · Cited by 198
Lower, E. E., Fleishman, S., Cooper, A., Zeldis, J., Faleck, H., Yu, Z., & Manning, D. (2009) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2009.03.011 · Cited by 197
Astrup, A., Madsbad, S., Breum, L., Jensen, T. J., Kroustrup, J. P., & Larsen, T. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61525-1 · Cited by 193
Escitalopram versus other antidepressive agents for depression
Cipriani, A., Santilli, C., Furukawa, T. A., Signoretti, A., Nakagawa, A., McGuire, H., Churchill, R., & Barbui, C. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006532.pub2 · Cited by 190
Verbalis, J. G., Adler, S., Schrier, R. W., Berl, T., Zhao, Q., Czerwiec, F. S., & _, _. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1078 · Cited by 189
Graham, J., & Coghill, D. (2008) · CNS Drugs · doi:10.2165/00023210-200822030-00003 · Cited by 185
El-Khalili, N., Joyce, M., Atkinson, S., Buynak, R. J., Datto, C., Lindgren, P., & Eriksson, H. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000015 · Cited by 185
Suppes, T. M., Datto, C. J., Minkwitz, M. C., Nordenhem, A., Walker, C., & Darko, D. F. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.10.007 · Cited by 182
Xerostomia and Hyposalivation: Causes, Consequences and Treatment in the Elderly
N??rhi, T. O., Meurman, J. H., & Ainamo, A. (1999) · Drugs & Aging · doi:10.2165/00002512-199915020-00004 · Cited by 180
Madersbacher, Halaska, Voigt, Alloussi, & Höfner (1999) · BJU International · doi:10.1046/j.1464-410x.1999.00251.x · Cited by 177
Zinner, N. R., Mattiasson, A., & Stanton, S. L. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50203.x · Cited by 166
A Double-Blind Comparison of Sertraline and Fluoxetine in Depressed Elderly Outpatients
Newhouse, P. A., Krishnan, K. R. R., Doraiswamy, P. M., Richter, E. M., Batzar, E. D., & Clary, C. M. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0804 · Cited by 163
Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy.
Tutka, P., & Zatoński, W. A. (2006) · PubMed · Cited by 160
Herschorn, S., Swift, S., Guan, Z., Carlsson, M., Morrow, J. D., Brodsky, M., & Gong, J. (2010) · BJU International · doi:10.1111/j.1464-410x.2009.09086.x · Cited by 159
Villa, A., Wolff, Ä., Aframian, D. J., Vissink, A., Ekström, J., Proctor, G., McGowan, R., Narayana, N., Aliko, A., Sia, Y. W., et al. (2015) · Clinical Oral Investigations · doi:10.1007/s00784-015-1488-2 · Cited by 159
Self-citationPollack, M., Kinrys, G., Krystal, A., McCall, W. V., Roth, T., Schaefer, K., Rubens, R., Roach, J., Huang, H., & Krishnan, R. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.5.551 · Cited by 158
Devos, D., Krystkowiak, P. C., Clement, F., Dujardin, K., Cottencin, O., Waucquier, N., Ajebbar, K., Thielemans, B., Kroumova, M., Duhamel, A., et al. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.100016 · Cited by 153
Bupropion Sustained Release Versus Paroxetine for the Treatment of Depression in the Elderly
Weihs, K. L., Settle, E. C., Batey, S. R., Houser, T. L., Donahue, R. M. J., & Ascher, J. A. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0309 · Cited by 150
Ballenger, J. C. (2011) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/j.ypsy.2010.10.088 · Cited by 146
Wilfley, D. E., Crow, S. J., Hudson, J. I., Mitchell, J. E., Berkowitz, R. I., Blakesley, V. A., & Walsh, B. T. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06121970 · Cited by 144
Villa, A., Wolff, Ä., Narayana, N., Dawes, C., Aframian, D., Pedersen, A. M. L., Vissink, A., Aliko, A., Sia, Y. W., Joshi, R. K., et al. (2015) · Oral Diseases · doi:10.1111/odi.12402 · Cited by 143
Self-citationNefazodone: A Review of its Pharmacology and Clinical Efficacy in the Management of Major Depression
Davis, R., Whittington, R., & Bryson, H. M. (1997) · Drugs · doi:10.2165/00003495-199753040-00006 · Cited by 142
Use of Antiepileptic Drugs in the Treatment of Chronic Painful Diabetic Neuropathy
Vinik, A. I. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2376 · Cited by 140
Lee, E., & LEE, C. (1997) · British Journal of Urology · doi:10.1046/j.1464-410x.1997.00411.x · Cited by 138
Mirabegron: a review of recent data and its prospects in the management of overactive bladder
Sacco, E., & Bientinesi, R. (2012) · Therapeutic Advances in Urology · doi:10.1177/1756287212457114 · Cited by 138
Cutler, A. J., Montgomery, S., Feifel, D., Lazarus, A. L., Åström, M., & Brecher, M. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04592 · Cited by 137
Oral side‐effects of the most frequently prescribed drugs
Smith, R. G., & Burtner, A. P. (1994) · Special Care in Dentistry · doi:10.1111/j.1754-4505.1994.tb01112.x · Cited by 134
Liebowitz, M. R., Manley, A. L., Padmanabhan, S. K., Ganguly, R., Tummala, R., & Tourian, K. A. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802161923 · Cited by 134
Wilde, M. I., & Benfield, P. (1995) · Drugs · doi:10.2165/00003495-199549030-00007 · Cited by 129
Homma, Y., Paick, J., Lee, J. G., et al. (2003) · British Journal of Urology · doi:10.1046/j.1464-410x.2003.04468.x · Cited by 126
GORDON, A. S., Callaghan, D. J. G., Spink, D., Cloutier, C., Dzongowski, P., O’Mahony, W. F., Sinclair, D., Rashiq, S., Buckley, N., & Cohen, G. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.04.018 · Cited by 126
Vieta, E., Nuamah, I. F., Lim, P., Yuen, E., Palumbo, J., Hough, D. W., & Berwaerts, J. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00815.x · Cited by 122
Contemporary management of depression
Andrews, J., & Nemeroff, C. B. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90360-3 · Cited by 120
Hening, W. A., Allen, R. P., Ondo, W. G., Walters, A. S., Winkelman, J. W., Becker, P. M., Bogan, R., Fry, J. M., Kudrow, D., Lesh, K. W., et al. (2010) · Movement Disorders · doi:10.1002/mds.23157 · Cited by 118
Asenapine versus olanzapine in acute mania: a double‐blind extension study
McIntyre, R. S., Cohen, M., Zhao, J., Alphs, L. D., Macek, T. A., & Panagides, J. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00749.x · Cited by 115
Bridle, C., Palmer, S. C., Bagnall, A., Darbà, J., Duffy, S., Sculpher, M. J., & Riemsma, R. P. (2004) · Health Technology Assessment · doi:10.3310/hta8190 · Cited by 114
Atomoxetine: A Review of its Use in Adults with Attention Deficit Hyperactivity Disorder
Simpson, D., & Plosker, G. L. (2004) · Drugs · doi:10.2165/00003495-200464020-00005 · Cited by 113
Fang, P., Hu, J., Cheng, Z., Liu, Z., Wang, J., & Jiao, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049717 · Cited by 112
Dry Mouth, The Malevolent Symptom: A Clinical Guide
Sreebny, L. M., & Vissink, A. (2010) · Medical Entomology and Zoology · Cited by 111
Self-citationAn Open-Label Study of the Treatment Efficacy of Olanzapine for Tourette's Disorder
Budman, C. L., GAYER, A. I., LESSER, M. L., Shi, Q., & BRUUN, R. D. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0412 · Cited by 111
Volz, H., & Gleiter, C. H. (1998) · Drugs & Aging · doi:10.2165/00002512-199813050-00002 · Cited by 110
Flupirtine: A Review of its Pharmacological Properties, and Therapeutic Efficacy in Pain States
Friedel, H. A., & Fitton, A. (1993) · Drugs · doi:10.2165/00003495-199345040-00007 · Cited by 110
Aliko, A., Wolff, Ä., Dawes, C., Aframian, D. J., Proctor, G., Ekström, J., Narayana, N., Villa, A., Sia, Y. W., Joshi, R. K., et al. (2015) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2014.10.027 · Cited by 110
Self-citationSmidt, D., Torpet, L. A., Nauntofte, B., Heegaard, K. M., & Pedersen, A. M. L. (2010) · Community Dentistry And Oral Epidemiology · doi:10.1111/j.1600-0528.2010.00588.x · Cited by 108
Self-citationStimulant-Responsive and Stimulant-Refractory Aggressive Behavior Among Children With ADHD
Blader, J. C., Pliszka, S. R., Jensen, P. S., Schooler, N. R., & Kafantaris, V. (2010) · Pediatrics · doi:10.1542/peds.2010-0086 · Cited by 106
A retrospective pooled analysis of duloxetine safety in 23 983 subjects
Gahimer, J., Wernicke, J., Yalcin, I., Ossanna, M. J., Wulster-Radcliffe, M. C., & Viktrup, L. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x162719 · Cited by 104
Moldofsky, H., HARRIS, H. W., Archambault, W. T., KWONG, T., & Lederman, S. M. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.110194 · Cited by 98
Semel, D., Murphy, T. K., Zlateva, G., Cheung, R. Y., & Emir, B. (2010) · BMC Family Practice · doi:10.1186/1471-2296-11-85 · Cited by 97
Adverse Effects of Atypical Antipsychotics in the Elderly: A Review
Gareri, P., Fazio, P. D., Fazio, S. D., Marigliano, N. M., Ibbadu, G. F., & Sarro, G. D. (2006) · Drugs & Aging · doi:10.2165/00002512-200623120-00002 · Cited by 96
Guerdjikova, A. I., McElroy, S. L., Kotwal, R., Welge, J. A., Nelson, E. B., Lake, K., Alessio, D. D., Keck, P. E., & Hudson, J. I. (2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.899 · Cited by 96
Khajavi, D., Farokhnia, M., Modabbernia, A., Ashrafi, M., Abbasi, S.-H., Tabrizi, M. H., & Akhondzadeh, S. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m07706 · Cited by 94
Smidt, D., Torpet, L. A., Nauntofte, B., Heegaard, K. M., & Pedersen, A. M. L. (2010) · Community Dentistry And Oral Epidemiology · doi:10.1111/j.1600-0528.2010.00554.x · Cited by 93
Self-citationPedersen, A. M. L., Nauntofte, B., Smidt, D., & Torpet, L. (2015) · Oral Diseases · doi:10.1111/odi.12337 · Cited by 93
Self-citationDavis, R., & Faulds, D. M. (1996) · Drugs · doi:10.2165/00003495-199652050-00007 · Cited by 93
Duloxetine: A Review of its Use in the Treatment of Major Depressive Disorder
Frampton, J. E., & Plosker, G. L. (2007) · CNS Drugs · doi:10.2165/00023210-200721070-00004 · Cited by 93
Curran, M. P., & Robinson, D. M. (2008) · Drugs · doi:10.2165/00003495-200868070-00007 · Cited by 91
Puri, B. K., Counsell, S. J., Ross, B. M., Hamilton, G., Bustos, M. G., & Treasaden, I. H. (2008) · BMC Psychiatry · doi:10.1186/1471-244x-8-s1-s2 · Cited by 89
Kim, K. K., Cho, H.-J., Kang, H.-C., Youn, B.-B., & Lee, K.-R. (2006) · Yonsei Medical Journal · doi:10.3349/ymj.2006.47.5.614 · Cited by 88
An Open-Label Trial of Aripiprazole Monotherapy in Children and Adolescents with Bipolar Disorder
Biederman, J., Mick, E. O., Spencer, T. J., Doyle, R., Joshi, G., Hammerness, P. G., Kotarski, M., Aleardi, M., & Wozniak, J. R. (2007) · CNS Spectrums · doi:10.1017/s1092852900021519 · Cited by 88
Homma, Y., Yamaguchi, O., & Imidafenacin Study Group (2009) · International Journal of Urology · doi:10.1111/j.1442-2042.2009.02286.x · Cited by 87
Adverse drug reactions in hospital in-patients: a pilot study
Davies, E. C., Green, C. F., Mottram, D. R., et al. (2006) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2006.00744.x · Cited by 87
D, M. F. M., Asnis, G. M., Shrivastava, R. K., Lydiard, B., Bastani, B., Sheehan, D. V., & Roth, T. G. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05571gry · Cited by 87
Aspects of Tolerability of Centrally Acting Antihypertensive Drugs
Webster, J., & Koch, H. (1996) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199627003-00007 · Cited by 87
Zacny, J. P., Lichtor, J. L., Flemming, D. C., Coalson, D. W., & Thompson, W. K. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38451-x · Cited by 86
Findling, R. L., McKenna, K., Earley, W. R., Stankowski, J. E., & Pathak, S. (2012) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0092 · Cited by 86
Muller, F. (2008) · International Journal of COPD · doi:10.2147/copd.s2654 · Cited by 83
Narcolepsy: current treatment options and future approaches
Mamelak, M. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s484 · Cited by 83
Bennett, J. P., Landow, E. R., & Schuh, L. A. (1993) · Neurology · doi:10.1212/wnl.43.8.1551 · Cited by 83
Effectiveness of second generation antipsychotics: A systematic review of randomized trials
Johnsen, E., & Jørgensen, H. A. (2008) · BMC Psychiatry · doi:10.1186/1471-244x-8-31 · Cited by 83
Katzman, M. A., Brawman‐Mintzer, O., Reyes, E. B., Olausson, B., Liu, S., & Eriksson, H. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32833e34d9 · Cited by 82
Duloxetine: A Review of its Use in the Treatment of Generalized Anxiety Disorder
Carter, N. J., & McCormack, P. L. (2009) · CNS Drugs · doi:10.2165/00023210-200923060-00006 · Cited by 81
Arnold, L. M., Clauw, D. J., WANG, F., AHL, J. S. B., Gaynor, P. J., & Wohlreich, M. M. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.100365 · Cited by 81
Steigerwald, I., Müller, M., Davies, A. F., Samper, D., Sabatowski, R., Baron, R., Rozenberg, S., Szczepańska-Szerej, A., Gatti, A., & Kress, H. G. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.679254 · Cited by 80
Comparison of tramadol with morphine for post-operative pain following abdominal surgery
Vickers, M. D., Paravicini, D., & Morant, S. V. (1996) · European Journal of Anaesthesiology · doi:10.1097/00003643-199607000-00023 · Cited by 80
Sathyan, G., Chancellor, M. B., & Gupta, S. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01463.x · Cited by 78
Kaya, A., Aydın, N., Topsever, P., Filiz, M., Öztürk, A., Dağar, A., Kılınç, E., & Ekmekçioğlu, C. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.09.006 · Cited by 77
Adverse events related to olanzapine.
Conley, R. R., & Meltzer, H. Y. (2000) · PubMed · Cited by 76
de Almeida, P. D. V., Grégio, A. M. T., Brancher, J. A., Ignácio, S. A., Machado, M. Â. N., de Lima, A. A. S., & de Azevedo, L. R. (2008) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2007.11.008 · Cited by 72
Crossover comparison of moxonidine and clonidine in mild to moderate hypertension
Pl�nitz, V. (1984) · European Journal of Clinical Pharmacology · doi:10.1007/bf00544037 · Cited by 71
Versiani, M., Amin, M., & Chouinard, G. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200002000-00006 · Cited by 70
Approaches to the enhancement of patient adherence to antidepressant medication treatment.
Delgado, P. L. (2000) · PubMed · Cited by 69
Evaluation of Cognitive Function in Healthy Older Subjects Treated with Fesoterodine
Kay, G. G., Maruff, P. T., Scholfield, D., Malhotra, B. K., Whelan, L., Darekar, A., & Martire, D. L. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.05.2543 · Cited by 68
Merideth, C., Cutler, A. J., She, F., & Eriksson, H. (2011) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32834d9f49 · Cited by 68
Vongpatanasin, W., Kario, K., Atlas, S. A., & Victor, R. G. (2011) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00509.x · Cited by 67
Venlafaxine for the control of hot flashes: results of a longitudinal continuation study.
Barton, D., Vasseur, B. L., Loprinzi, C., Novotny, P., Wilwerding, M. B., & Sloan, J. (2002) · Oncology Nursing Forum · doi:10.1188/02.onf.33-40 · Cited by 66
McEvoy, J. P., Citrome, L., Hernandez, D., et al. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m07992 · Cited by 65
Effect of verapamil on human intestinal transit
Krevsky, B., Maurer, A. H., Niewiarowski, T. J., & Cohen, S. (1992) · Digestive Diseases and Sciences · doi:10.1007/bf01300391 · Cited by 65
Feighner, J. P., Entsuah, A. R., & McPherson, M. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00109-2 · Cited by 64
Effectiveness of Tizanidine in Neuropathic Pain: An Open-Label Study
Semenchuk, M. R., & Sherman, S. J. (2000) · Journal of Pain · doi:10.1054/jpai.2000.9435 · Cited by 64
Nefazodone: A new Antidepressant
Ellingrod, V. L., & Perry, P. J. (1995) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/52.24.2799 · Cited by 63
Asthma Medications and their Potential Adverse Effects in the Elderly
Newnham, D. M. (2001) · Drug Safety · doi:10.2165/00002018-200124140-00005 · Cited by 62
Pharmacotherapy for anxiety disorders in children and adolescents
Kodish, I., Rockhill, C., & Varley, C. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.4/ikodish · Cited by 62
Clinical efficacy of reboxetine in major depression.
Schatzberg, A. F. (2000) · PubMed · Cited by 61
Escitalopram versus venlafaxine XR in the treatment of depression
Montgomery, S., & Andersen, H. F. (2006) · International Clinical Psychopharmacology · doi:10.1097/00004850-200609000-00008 · Cited by 60
Pigott, T. A., Prakash, A., Arnold, L. M., Aaronson, S. T., Mallinckrodt, C. H., & Wohlreich, M. M. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x188107 · Cited by 60
Hewett, K., Chrzanowski, W., Schmitz, M., Savela, A., Milanova, V, Gee, M., Krishen, A., Millen, L., Leary, M., & Modell, J. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108089602 · Cited by 57
Rothschild, A. J., Mahableshwarkar, A. R., Jacobsen, P. L., Yan, M., & Sheehan, D. V. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.07.011 · Cited by 57
Tramontina, S., Zeni, C., Pheula, G. F., de Souza, C. K., & Rohde, L. A. (2007) · CNS Spectrums · doi:10.1017/s1092852900015443 · Cited by 56
Villaseca, P. (2011) · Climacteric · doi:10.3109/13697137.2011.624214 · Cited by 56
Impact of CYP2C19 Polymorphisms on the Efficacy of Clobazam Therapy
Seo, T., Nagata, R., Ishitsu, T., Murata, T., Takaishi, C., Hori, M., & Nakagawa, K. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.5.527 · Cited by 55
Pharmacotherapy for Anxiety Disorders in Children and Adolescents
Kodish, I. M., Rockhill, C., Ryan, S. A., & Varley, C. (2011) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2010.10.002 · Cited by 54
Efficacy of Noradrenergic and Serotonergic Antidepressants in Chronic Back Pain
Atkinson, J. H., Slater, M. A., Capparelli, E. V., Wallace, M. S., Zisook, S., ABRAMSON, I. S., Matthews, S. C., & Garfin, S. R. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3180333ed5 · Cited by 53
Electrocardiographic Effects of Fluoxetine and Doxepin in Patients With Major Depressive Disorder
Baker, B., Dorian, P., Sandor, P., Shapiro, C. M., Schell, C., Mitchell, J., & Irvine, M. J. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199702000-00004 · Cited by 53
Joffe, H., Partridge, A. H., Giobbie‐Hurder, A., Li, X., Habin, K. R., Goss, P. E., Winer, E. P., & Garber, J. E. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181dbee1b · Cited by 53
Chancellor, M. B., Zinner, N. R., WHITMORE, K. E., Kobashi, K. C., Snyder, J. A., Siami, P. F., Karram, M. M., Laramée, C., Capo', J. P., Seifeldin, R., et al. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.10.011 · Cited by 51
Eszopiclone: its use in the treatment of insomnia
Monti, J. M., & Pandi-Perumal, S. R. (2007) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a916 · Cited by 50
Kendirci, M., Salem, E. A., & Hellstrom, W. J. G. (2007) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.2007.3.2.277 · Cited by 50
Adams, C. E., Rathbone, J., Thornley, B., Clarke, M. J., Borrill, J., Wahlbeck, K., & Awad, A. G. (2005) · BMC Medicine · doi:10.1186/1741-7015-3-15 · Cited by 49
Effects of Antihypertensive Medications on Quality of Life in Elderly Hypertensive Women
Croog, S. H., Elias, M. F., Colton, T., Baume, R. M., Leiblum, S. R., Jenkins, C. D., Perry, M., & Hall, W. D. (1994) · American Journal of Hypertension · doi:10.1093/ajh/7.4.329 · Cited by 49
Duloxetine in the management of diabetic peripheral neuropathic pain
Boomershine, C. S., Ormseth, M. J., & Scholz, B. A. (2011) · Patient Preference and Adherence · doi:10.2147/ppa.s16358 · Cited by 48
Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review
Fountoulakis, K. Ν., & Vieta, E. (2009) · Annals of General Psychiatry · doi:10.1186/1744-859x-8-16 · Cited by 46
Modafinil in the treatment of excessive sleepiness
Schwartz, J. R. L. (2008) · Drug Design Development and Therapy · doi:10.2147/dddt.s2377 · Cited by 46
Malone, R. P., Gratz, S. S., Delaney, M. A., & Hyman, S. L. (2005) · CNS Drugs · doi:10.2165/00023210-200519110-00003 · Cited by 45
Centrally acting antihypertensives
van Zwieten, P. A. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715011-00001 · Cited by 45
Differential effects of new‐generation H1‐receptor antagonists in pruritic dermatoses
Henz, B. M., Metzenauer, P., O'Keefe, E., & Zuberbier, T. (1998) · Allergy · doi:10.1111/j.1398-9995.1998.tb03867.x · Cited by 43
Jafarinia, M., Mohammadi, M., Modabbernia, A., Ashrafi, M., Khajavi, D., Tabrizi, M., Yadegari, N., & Akhondzadeh, S. (2012) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2242 · Cited by 42
Efficacy of venlafaxine in geriatric depression
Staab, J. P., & Evans, D. L. (2000) · Depression and Anxiety · doi:10.1002/1520-6394(2000)12:1+<63::aid-da8>3.0.co;2-t · Cited by 42
Arnold, L. M., Zhang, S., & Pangallo, B. A. (2012) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e3182510295 · Cited by 41
Staskin, D. R., Rosenberg, M. T., Dahl, N. V., Polishuk, P. V., & Zinner, N. R. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01625.x · Cited by 39
Mangel, A. W., & Hicks (2012) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s23274 · Cited by 39
Mattiasson, A., Masala, A., Morton, R., et al. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08910.x · Cited by 38
Kasper, S., Möller, H. J., Montgomery, S. A., & Zondag, E. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199501004-00001 · Cited by 37
Wellington, K., & Jarvis, B. (2001) · Drugs · doi:10.2165/00003495-200161150-00009 · Cited by 37
Kay, G. G., Staskin, D. R., MacDiarmid, S., McIlwain, M., & Dahl, N. V. (2012) · Clinical Drug Investigation · doi:10.1007/bf03261924 · Cited by 35
Kalman, D., Herz, L. R., Monti, P. M., Kahler, C. W., Mooney, M. E., Rodrigues, S., & O’Connor, K. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.03.005 · Cited by 34
Storms, W. W. (1996) · Drugs · doi:10.2165/00003495-199600521-00006 · Cited by 34
Safety, tolerability and risk benefit analysis of tiotropium in COPD
Oba, Y., Zaza, & Thameem (2008) · International Journal of COPD · doi:10.2147/copd.s3530 · Cited by 33
Clozapine: Agonistic and Antagonistic Salivary Secretory Actions
Ekström, J., Godoy, T., & Riva, A. (2010) · Journal of Dental Research · doi:10.1177/0022034509356055 · Cited by 33
Self-citationPapakostas, G. I., Vitolo, O. V., IsHak, W. W., Rapaport, M. H., Zajecka, J., Kinrys, G., Mischoulon, D., Lipkin, S., Hails, K. A., Abrams, J., et al. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m07670 · Cited by 32
Efficacy, Safety and Tolerability of Fesoterodine in Asian Patients with Overactive Bladder
Yamaguchi, O., Nishizawa, O. I., Takeda, M., et al. (2011) · LUTS Lower Urinary Tract Symptoms · doi:10.1111/j.1757-5672.2011.00091.x · Cited by 32
The efficacy of milnacipran in panic disorder: an open trial
Blaya, C., Seganfredo, A. C. G., Dornelles, M., Torres, M., Paludo, A. P., Heldt, E., & Manfro, G. G. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32802c7bf5 · Cited by 31
Weisler, R., Montgomery, S., Earley, W., Szamosi, J., & Lazarus, A. (2012) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32834d6f91 · Cited by 30
Kornstein, S. G., Clayton, A. H., Soares, C. N., Padmanabhan, S. K., & Guico‐Pabia, C. J. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181dcb594 · Cited by 29
Stewart, D. E., Wohlreich, M. M., Mallinckrodt, C. H., Watkin, J. G., & Kornstein, S. G. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.04.006 · Cited by 29
Brown, T. E., Brams, M., Gao, J., Gasior, M., & Childress, A. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.09.2196 · Cited by 29
Riahi, F., Tehrani‐Doost, M., Shahrivar, Z., & Alaghband‐Rad, J. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1158 · Cited by 29
Sauer, H., Huppertz-Helmhold, S., & Dierkes, W. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-43052 · Cited by 28
Duloxetine in the Treatment of Stress Urinary Incontinence
Michel, M. C., & Oelke, M. (2005) · Women s Health · doi:10.2217/17455057.1.3.345 · Cited by 28
Milnacipran for the management of fibromyalgia syndrome
Boomershine, C. (2010) · Journal of Pain Research · doi:10.2147/jpr.s7883 · Cited by 28
Methylphenidate Side Effects in Advanced Cancer: A Retrospective Analysis
Lasheen, W., Walsh, D., Mahmoud, F. A., Davis, M. P., Rivera, N. I., & Seyidova-Khoshknabi, D. (2009) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909109345145 · Cited by 28
Chu, F. M., Smith, N. N., & Uchida, T. (2009) · Current Therapeutic Research · doi:10.1016/j.curtheres.2009.11.001 · Cited by 28
Salivary Flow Rate in Patients With Schizophrenia on Clozapine
Praharaj, S. K., Jana, A. K., Goswami, K., Das, P. R., Goyal, N., & Sinha, V. K. (2010) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181e204e0 · Cited by 27
Sertindole: A Review of its Use in Schizophrenia
Murdoch, D. R., & Keating, G. M. (2006) · CNS Drugs · doi:10.2165/00023210-200620030-00005 · Cited by 27
Novel Antidepressants and Panic Disorder: Evidence beyond Current Guidelines
Serretti, A., Chiesa, A., Calati, R., Perna, G., Bellodi, L., & Ronchi, D. D. (2010) · Neuropsychobiology · doi:10.1159/000321831 · Cited by 27
Ball, S. G., Desaiah, D., Zhang, Q., Thase, M., & David, P. (2013) · Drugs in Context · doi:10.7573/dic.212245 · Cited by 26
Timdahl, K., Carlsson, A., & Stening, G. (2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.853 · Cited by 25
Lauti, M., Herbison, P., Hay‐Smith, J., Ellis, G., & Wilson, D. (2008) · International Urogynecology Journal · doi:10.1007/s00192-008-0686-8 · Cited by 24
Stauffer, V. L., Sniadecki, J., Piezer, K. W., Gatz, J. L., Kollack‐Walker, S., Hoffmann, V. P., Conley, R. R., & Durell, T. M. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-89 · Cited by 23
Antiretroviral therapy: effects on orofacial health and health care
Dios, P. D., & Scully, C. M. (2013) · Oral Diseases · doi:10.1111/odi.12093 · Cited by 23
Pharmacotherapy for Fibromyalgia
Smith, H. S., Bracken, D., & Smith, J. M. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00017 · Cited by 23
Adverse effects with use of nicotine replacement therapy among quitline clients
Ossip, D. J., Abrams, S. M., Mahoney, M. C., Sall, D. R., & Cummings, K. M. (2009) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntp005 · Cited by 21
Nguyen, C. T., MacEntee, M. I., Mintzes, B. J., & Perry, T. L. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0141-5 · Cited by 21
Bupropion sustained release. A therapeutic review of Zyban.
Zwar, N. A., & RICHMOND, R. L. (2002) · PubMed · Cited by 21
Duloxetine in the treatment of generalized anxiety disorder
Norman, T. R., & Olver, J. S. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2820 · Cited by 20
Ba, S., Carmichael, H., & Wilson, M. (1996) · PubMed · Cited by 19
Clinical Efficacy of Ebastine in the Treatment and Prevention of Seasonal Allergic Rhinitis
Peláez, A. (1996) · Drugs · doi:10.2165/00003495-199600521-00009 · Cited by 18
Canuso, C. M., Turkoz, I., Sheehan, J. J., & Bossie, C. A. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.05.025 · Cited by 17
Duloxetine in the treatment of generalized anxiety disorder
Berg, C. V., & Wright (2009) · International Journal of General Medicine · doi:10.2147/ijgm.s4492 · Cited by 17
Jain, T., Bhandari, A. K., Ram, V., Parakh, M., Wal, P., & Naik, A. N. (2011) · Cited by 17
Effect Size of Lisdexamfetamine Dimesylate in Adults with Attention-Deficit/Hyperactivity Disorder
Wigal, T., Brams, M., Gasior, M., Gao, J., & Giblin, J. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.03.2275 · Cited by 16
David, P., Kajdasz, D. K., Royer, M. G., Walker, D. J., & Raskin, J. (2006) · International Clinical Psychopharmacology · doi:10.1097/00004850-200609000-00007 · Cited by 16
A 10-Month, Open-Label Evaluation of Desvenlafaxine in Outpatients With Major Depressive Disorder
Tourian, K. A., Pitrosky, B., Padmanabhan, S. K., & Rosas, G. R. (2011) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.10m00977blu · Cited by 15
Veselinović, T., Schorn, H., Vernaleken, I., Schiffl, K., Hiemke, C., Zernig, G., Gur, R. C., & Gründer, G. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2368-3 · Cited by 15
Cited by
Salivary secretion in health and disease
Pedersen, A. M. L., Sørensen, C. E., Proctor, G. B., Carpenter, G. H., & Ekström, J. (2018) · Journal of Oral Rehabilitation · doi:10.1111/joor.12664 · Cited by 571
Self-citationSjögren’s syndrome: a systemic autoimmune disease
Negrini, S., Emmi, G., Greco, M., Borro, M., Sardanelli, F., Murdaca, G., Indiveri, F., & Puppo, F. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-021-00728-6 · Cited by 459
Salivary functions in mastication, taste and textural perception, swallowing and initial digestion
Pedersen, A., Sørensen, C., Proctor, G., & Carpenter, G. (2018) · Oral Diseases · doi:10.1111/odi.12867 · Cited by 281
Self-citationRole of Saliva and Salivary Diagnostics in the Advancement of Oral Health
Dawes, C., & Wong, D. T. W. (2019) · Journal of Dental Research · doi:10.1177/0022034518816961 · Cited by 218
Self-citationFereshtehnejad, S., Garcia‐Ptacek, S., Religa, D., Holmer, J., Buhlin, K., Eriksdotter, M., & Sandborgh‐Englund, G. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.05.004 · Cited by 81
Metadata
- Authors
- Wolff, A., Joshi, R. K., Ekström, J., Aframian, D., Pedersen, A. M. L., Proctor, G., Narayana, N., Villa, A., Sia, Y. W., Aliko, A., McGowan, R., Kerr, A. R., Jensen, S. B., Vissink, A., & Dawes, C.
- Venue
- Drugs in R&D
- Published
- 2016-11-16
- Volume
- 17
- Issue
- 1
- Pages
- 1-28
- ISSN
- 1174-5886 (ISSN-L)
- 1179-6901
- OpenAlex
- W2556835195
- Cited by
- 364
- References
- 215
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.